These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Update on vaccine development in AIDS and cancer. MacDougall DS J Int Assoc Physicians AIDS Care; 1995 Apr; 1(3):18-24. PubMed ID: 11362485 [TBL] [Abstract][Full Text] [Related]
4. [Recent topics on AIDS research-- study of AIDS viruses and the application for development of prevention and therapeutic methods of AIDS]. Honda M Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):606-7. PubMed ID: 8963762 [No Abstract] [Full Text] [Related]
5. AIDS vaccines inch closer to useful existence. Goldsmith MF JAMA; 1991 Mar; 265(11):1356-7. PubMed ID: 1999873 [No Abstract] [Full Text] [Related]
6. Modern approaches to new vaccines, including prevention of AIDS. 16-22 September 1992, Cold Spring Harbor, Long Island, NY. Spier RE Vaccine; 1993; 11(7):789-90. PubMed ID: 8102024 [No Abstract] [Full Text] [Related]
7. [An update and the outlook in vaccination against HIV/AIDS]. Ivan A; Azoicăi D; Mitroi I Rev Med Chir Soc Med Nat Iasi; 1991; 95(1-2):207-10. PubMed ID: 1823419 [No Abstract] [Full Text] [Related]
8. AIDS vaccines. Testing target date looms, but will the vaccines be ready? Palca J Science; 1992 Sep; 257(5076):1472-3. PubMed ID: 1523403 [No Abstract] [Full Text] [Related]
9. [Nucleic acid vaccines for study in AIDS patients are approved. Vaccines of genetic molecules--humoral and cellular immune response]. Hobom B Fortschr Med; 1995 Dec; 113(35-36):12. PubMed ID: 8582688 [No Abstract] [Full Text] [Related]
10. Vaccines in AIDS. Present state of knowledge. Barrett PN; Dorner F Int Arch Allergy Immunol; 1993; 100(2):93-8. PubMed ID: 8443471 [TBL] [Abstract][Full Text] [Related]
11. AIDS vaccines. Are researchers racing toward success, or crawling? Cohen J Science; 1994 Sep; 265(5177):1373-5. PubMed ID: 8073272 [No Abstract] [Full Text] [Related]
12. AIDS research. Merck reemerges with a bold AIDS vaccine effort. Cohen J Science; 2001 Apr; 292(5514):24-5. PubMed ID: 11294193 [No Abstract] [Full Text] [Related]
13. Canadian lab to produce HIV immunogen for clinical trials. CMAJ; 1990 Nov; 143(9):907. PubMed ID: 2224719 [No Abstract] [Full Text] [Related]
14. Phase I trial of potential AIDS vaccine commences. Oncology (Williston Park); 1991 May; 5(5):182. PubMed ID: 1832002 [No Abstract] [Full Text] [Related]
15. Challenges and strategies for AIDS vaccine development. Oxford JS; Frezza P; Race E Vaccine; 1993; 11(6):612-4. PubMed ID: 8100664 [TBL] [Abstract][Full Text] [Related]
16. AIDS/HIV. A STEP into darkness or light? Moore JP; Klasse PJ; Dolan MJ; Ahuja SK Science; 2008 May; 320(5877):753-5. PubMed ID: 18467578 [No Abstract] [Full Text] [Related]
17. AIDS research. Debate begins over new vaccine trials. Cohen J Science; 2001 Sep; 293(5537):1973. PubMed ID: 11557856 [No Abstract] [Full Text] [Related]
18. Immunization for long-term protection against AIDS using the macaque model. Kumar A; Narayan O Virology; 2001 Jun; 285(1):1-5. PubMed ID: 11414799 [No Abstract] [Full Text] [Related]
19. A strategy for accelerating the development of preventive AIDS vaccines. Excler JL; Rida W; Priddy F; Fast P; Koff W AIDS; 2007 Nov; 21(17):2259-63. PubMed ID: 18090273 [No Abstract] [Full Text] [Related]
20. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model. Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]